Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics
GILCHUK ET AL. 2020. NATURE BIOMED ENG 4:1030-1043.
RESOURCES
Where research scientists come to find up to date resources on antibody discovery against challenging membrane protein targets.
Category: Virology
Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications
WHITBECK ET AL. 2020. PLoS NEGL TROP DIS 14(11): e0008730.
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
DUSSUPT ET AL. 2020. NATURE MED 26:228-235.
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies
ILINYKH ET AL. 2020. CELL HOST MICROBE S1931-3128(20)30189
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
GILCHUCK ET AL. 2020. IMMUNITY 52:1-16.
Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection
WAICKMAN ET AL. 2020. EBIOMED 54:102733
Monoclonal antibody 2C6 targets cross-clade conformational epitope in GP41 with highly active antibody dependent cell cytotoxicity
SOJAR, ET AL. 2019. J VIROL, DOI:10.1128/JVI.00772-19
Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model
NIU, ET AL. 2019. EMERG MICROBES INFECT 8(1):749-759
Broadly Neutralizing Antibodies Targeting New Sites of Vulnerability in Hepatitis C Virus E1E2
COLBERT, ET AL. 2019. J VIROL, DOI: 10.1128/JVI.02070-18
